Please login to the form below

Not currently logged in


This page shows the latest Ozempic news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk set to acquire Emisphere Technology for $1.8bn

Novo Nordisk set to acquire Emisphere Technology for $1.8bn

Rothwell, chairman of Emisphere. Novo’s GLP-1 agonist franchise also includes Ozempic (semglutide) and Victoza (liraglutide).

Latest news

More from news
Approximately 11 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • NICE – but not enough NICE – but not enough

    Around the same time (late 2018), Novo Nordisk launched Ozempic, also for type 2 diabetes, though a different class (GLP1). ... market. As. you can see, Ozempic – which launched without a NICE TA – outperformed its rival.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...